Skip to main content
GutCited

Galactooligosaccharides (GOS) Figures

19 figures issues de recherches évaluées par des pairs

Tous Psyllium Husk Bifidobacterium lactis Fructooligosaccharides (FOS) Lactobacillus plantarum Peppermint Oil Pancreatic Enzymes (Pancrelipase) Curcumin Vitamin A Medium-Chain Triglycerides (MCT Oil) Galactooligosaccharides (GOS) Lactobacillus gasseri Aloe Vera (Inner Leaf Gel) Alpha-Galactosidase Vitamin D L-Glutamine Inulin Ginger Lactase Berberine Omega-3 Fatty Acids (EPA/DHA) Bovine Colostrum Zinc Bifidobacterium bifidum Butyrate (Sodium/Calcium Butyrate) Bacillus coagulans Saccharomyces boulardii Lactobacillus acidophilus N-Acetyl Cysteine (NAC) Bifidobacterium longum
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 1
Figure 1

The Canadian Association of Gastroenterology clinical practice guideline provides an evidence-based framework for managing irritable bowel syndrome, covering diagnosis, dietary modifications, pharmacological treatments, and psychological interventions.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

Figure 2
Figure 2 Flowchart

Diagnostic criteria for IBS rely on symptom-based assessment using Rome IV criteria, with limited use of diagnostic tests. Serological screening for celiac disease is recommended as part of the initial evaluation.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

The consensus group concluded that while studies suggest benefits with probiotic therapies overall, and with combination
Figure 3

Evidence evaluation for probiotic therapies in IBS suggests overall benefit, particularly with combination probiotic preparations. Strain-specific recommendations remain difficult due to heterogeneity in study designs and products evaluated.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

Figure 4
Figure 4

Dietary interventions for IBS include the low-FODMAP diet, which has demonstrated efficacy in reducing bloating, abdominal pain, and altered bowel habits. A dietitian-guided three-phase approach (restriction, reintroduction, personalization) is recommended.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

Key evidence: Two RCTs that fulfilled inclusion criteria for this consensus, compared polyethylene glycol 3350 (PEG) and placebo in a total of 181 patients with Rome (II or III) diagnosed IBS-C (165, 166). Compared with placebo, there was a statistically
Figure 5 Chart

Polyethylene glycol 3350 is evaluated for IBS with constipation based on two RCTs totaling 181 patients. Evidence supports its use for improving stool consistency, though effects on abdominal pain are less consistent.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

Figure 6
Figure 6

Antispasmodic agents including peppermint oil, pinaverium, and trimebutine receive conditional recommendations for IBS symptom management. Evidence quality varies across specific agents.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

IBS is diagnosed based on symptoms, with limited use of diagnostic tests; however, serological testing is suggested to exclude celiac disease.
Figure 7 Flowchart

An algorithmic approach to IBS management stratifies treatment by predominant bowel habit (IBS-C, IBS-D, IBS-M) and symptom severity. First-line interventions include dietary modification and fiber supplementation.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

Figure 8
Figure 8

Summary recommendations across all therapeutic categories for IBS are presented with corresponding evidence quality ratings and strength of recommendation. The guideline emphasizes shared decision-making with patients.

Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Irritable …

Figure 1. Likely mechanisms through which dietary fiber affects the functions of the gastrointestinal tract. Dietary fiber acts as a prebiotic to intestinal microbiota that causes changes in their composition and induces the growth of beneficial bacteria.
Figure 3 Diagram

Dietary fiber acts as a prebiotic for intestinal microbiota, promoting growth of beneficial bacteria and production of short-chain fatty acids. This diagram illustrates multiple mechanisms through which fiber affects gastrointestinal function, including modulation of gut microbiome composition and intestinal barrier integrity.

Dietary fiber in irritable bowel syndrome (Review).

Fig. 2. Gel-like images of the lentil protein sources under non-reducing and reducing conditions obtained from Bioanalyzer using an Agilent 80 + protein chip.
Figure 3 Micrograph

Gel-like electrophoresis images compare the protein molecular weight distribution of lentil protein sources under reducing and non-reducing conditions, revealing the impact of processing methods on protein subunit composition.

Nutritional and anti-nutritional properties of lentil (Lens culinaris) protein isolates prepared by …

Figure 1. Fructose, DP 2–7 FOS, and DP >7 FOS content of sourdough (35 g water; 35 g flour). p < 0.05 (c), p < 0.01 (b), and p < 0.0001 (a) indicate significant differences from the control. (A) Wheat sourdough; 4 °C; W700. (B) Wheat sourdough
Figure 6 Chart

Fructose, DP 2–7 FOS, and DP >7 FOS content of sourdough (35 g water; 35 g flour). p < 0.05 (c), p < 0.01 (b), and p < 0.0001 (a) indicate significant differences from the control.

FODMAP Fingerprinting of Bakery Products and Sourdoughs: Quantitative Assessment and Content Reduction …

Figure 7
Figure 7 Chart

Statistical analysis from research investigating FODMAP Fingerprinting of Bakery Products and Sourdoughs, comparing treatment groups and control conditions.

FODMAP Fingerprinting of Bakery Products and Sourdoughs: Quantitative Assessment and Content Reduction …

Figure 3. Arabinose, glucose, maltose, and mannitol contents of sourdough. (A) Wheat sourdough; 4 °C; W700. (B) Wheat sourdough; 10 °C; W700. ( ) Rye sourdough; 4 °C; R960. (D) Rye sourdough; 10 °C; R960.
Figure 8 Chart

Arabinose, glucose, maltose, and mannitol contents of sourdough. (A) Wheat sourdough; 4 °C; W700.

FODMAP Fingerprinting of Bakery Products and Sourdoughs: Quantitative Assessment and Content Reduction …

Figure 9
Figure 9 Chart

Graphical representation of outcomes in a study of FODMAP Fingerprinting of Bakery Products and Sourdoughs, highlighting trends observed across experimental conditions.

FODMAP Fingerprinting of Bakery Products and Sourdoughs: Quantitative Assessment and Content Reduction …

Figure 10
Figure 10 Chart

Quantitative data from a study on FODMAP Fingerprinting of Bakery Products and Sourdoughs, presenting measured outcomes relevant to the investigation of fermentable oligo-, di-, and monosaccharides and polyols (FODMAPs) are associated with digestive disorders and with d.

FODMAP Fingerprinting of Bakery Products and Sourdoughs: Quantitative Assessment and Content Reduction …

Figure 6
Figure 6

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic …

Figure 1. Flow diagram showing the selection of subjects for this study. FDr, functional diarrhea.
Figure 7

Figure 1. Flow diagram showing the selection of subjects for this study. FDr, functional diarrhea.

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic …

Figure 2. Changes in the percentage of loose and formed stools at baseline, 4 weeks, and 8 weeks after intervention. Changes in the proportion of formed and loose stools at (a) week 0 (baseline), (b)
Figure 8

Figure 2. Changes in the percentage of loose and formed stools at baseline, 4 weeks, and 8 weeks after intervention. Changes in the proportion of formed and loose stools at …

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic …

Figure 9
Figure 9

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effects of Multi-Strain Synbiotic …